Maurizio Puccetti
Forli, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
PSMA expression: enhancing prostate cancer diagnosis at the biopsy stage.
Journal: Minerva urology and nephrology
Published: July 07, 2026
Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer.
Journal: Biomedicines
Published: December 23, 2025
Unraveling the protein kinase C/NDRG1 signaling network in breast cancer.
Journal: Cell & bioscience
Published: June 25, 2024
Re: Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer.
Journal: Journal of the National Cancer Institute
Published: December 07, 2022
Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer".
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 05, 2022
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Journal: Translational oncology
Published: February 18, 2022
Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient.
Journal: Frontiers in medicine
Published: December 01, 2021
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects.
Journal: Frontiers in cell and developmental biology
Published: September 07, 2021
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer.
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer.
Journal: Frontiers in oncology
Published: February 19, 2021
Spotlight on PSMA as a new theranostic biomarker for bladder cancer.
Journal: Scientific reports
Published: December 10, 2020
Last Updated: 09/26/2026